Infectious Diseases News
Hepatitis C virus infection screening recommendations Jun 26, 2013 Baylor College of Medicine experts are supporting the latest recommendations by the Centers for Disease Control and Prevention regarding screening for hepatitis C virus infection.
Baylor pediatric HIV/AIDS program expands in Lesotho Jun 12, 2013 The Baylor College of Medicine International Pediatric AIDS Initiative (BIPAI) at Texas Children's Hospital will expand its clinical and educational efforts to reach the most remote villages of Lesotho with the opening of two new satellite clinical centers
Botswana-Baylor pediatric HIV/AIDS program celebrates 10th anniversary Jun 11, 2013 The Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital opened its first clinic 10 years ago in the region of Africa hardest hit by pediatric AIDS.
Kline to receive humanitarian awards from Houston-Galveston Schweitzer Fellows Program Apr 16, 2013 Kline is being honored for his extensive efforts to address pediatrics HIV/AIDS in Sub-Saharan Africa and global health.
Study shows HIV treatment outcomes of undocumented Hispanic patients Mar 28, 2013 Previous research has shown that the undocumented Hispanic population is fearful of reaching out for publically funded healthcare.
Food availability linked with poor outcomes for HIV-positive children Feb 6, 2013 Food insecurity can lead to patients skipping their antiretroviral medications, medications may not be absorbed as well on empty stomach.
Experts offer important reminders on World AIDS Day Nov 30, 2012 BCM experts stress reduce risky behaviors, know your HIV status.
West Nile Virus Q&A Aug 30, 2012 BCM experts answer questions about West Nile Virus.
Experts encourage screening West Nile patients for kidney disease Jul 12, 2012 BCM study finds the prevalence and progression of kidney disease in those previously infected with West Nile virus.
Baylor College of Medicine receives over $6 million from NIH to develop SARS vaccine May 22, 2012 SARS vaccine endeavor is BCM's first major effort to develop a vaccine for a potential public health emergency threat in U.S.